Switch to:
More From Other Websites
Friday’s 6 Biopharma Movers That Can’t Be Ignored Jan 06 2017
Pacira Pharmaceuticals Reports Preliminary 2016 Revenues of $276.4 Million Jan 06 2017
PACIRA PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Jan 06 2017
Pacira Pharmaceuticals Reports Preliminary 2016 Revenues of $276.4 Million Jan 06 2017
Pacira Pharmaceuticals, Inc. to Present at the 35th Annual J.P. Morgan Healthcare Conference Jan 03 2017
Coverage initiated on Pacira Pharma by H.C. Wainwright Jan 03 2017
Innocoll stock slides 65% after FDA setback for pain treatment Dec 30 2016
The Year in U.S. Equity Funds: Resilient in a Tumultuous 2016 Dec 30 2016
Pacira Pharmaceuticals, Inc. – Value Analysis (NASDAQ:PCRX) : December 27, 2016 Dec 27 2016
Pacira Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : PCRX-US :... Dec 26 2016
ETFs with exposure to Pacira Pharmaceuticals, Inc. : December 22, 2016 Dec 22 2016
Pacira A Likely Takeout Candidate Despite Anesthesia Sales Dip: Mizuho Dec 21 2016
ETFs with exposure to Pacira Pharmaceuticals, Inc. : December 12, 2016 Dec 12 2016
Should You Buy Pacira Pharmaceuticals Inc (PCRX)? Dec 08 2016
ETFs with exposure to Pacira Pharmaceuticals, Inc. : November 30, 2016 Nov 30 2016
Pacira Pharmaceuticals and GeneAlign Announce Partnership to Develop Low-Opioid Pain Management... Nov 29 2016
American College of Surgeons Launches Education Program on Opioids and Surgery: Use, Abuse, and... Nov 22 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK